title: Plasmodium vivax malaria vaccine development.
abstract: Plasmodium vivax represents the most widespread malaria parasite worldwide. Although it does not result in as high a mortality rate as P. falciparum, it inflicts debilitating morbidity and consequent economic impact in endemic communities. In addition, the relapsing behavior of this malaria parasite and the recent resistance to anti-malarials contribute to making its control more difficult. Although the biology of P. vivax is different from that of P. falciparum and the human immune response to this parasite species has been rather poorly studied, significant progress is being made to develop a P. vivax-specific vaccine based on the information and experience gained in the search for a P. falciparum vaccine. We have devoted great effort to antigenically characterize the P. vivax CS protein and to test its immunogenicity using the Aotus monkey model. Together with other groups we are also assessing the immunogenicity and protective efficacy of the asexual blood stage vaccine candidates MSP-1 and DBP in the monkey model, as well as the immunogenicity of Pvs25 and Pvs28 ookinete surface proteins. The transmission-blocking efficacy of the responses induced by these latter antigens is being assessed using Anopheles albimanus mosquitoes. The current status of these vaccine candidates and other antigens currently being studied is described.
authors.affiliation: Immunology Institute, Universidad del Valle, Cali, Colombia. marami@inmuno.univalle.edu.co
authors.forename: M
authors.initials: M
authors.lastname: Arévalo-Herrera
authors.forename: S
authors.initials: S
authors.lastname: Herrera
mesh_terms: D000818:Animals; D000953:Antigens, Protozoan / Q000032:analysis / Q000276:immunology*; D002352:Carrier Proteins / Q000032:analysis / Q000276:immunology; D000882:Haplorhini; D006801:Humans; D017780:Malaria Vaccines; D016780:Malaria, Vivax / Q000276:immunology* / Q000517:prevention & control*; D020066:Merozoite Surface Protein 1 / Q000032:analysis / Q000276:immunology; D010966:Plasmodium vivax / Q000276:immunology*; D015800:Protozoan Proteins / Q000032:analysis / Q000276:immunology; D011956:Receptors, Cell Surface / Q000032:analysis / Q000276:immunology
chemical_list: D000953:Antigens, Protozoan; D002352:Carrier Proteins; C066001:Duffy antigen binding protein, Plasmodium; D017780:Malaria Vaccines; D020066:Merozoite Surface Protein 1; D015800:Protozoan Proteins; D011956:Receptors, Cell Surface; C041595:circumsporozoite protein, Protozoan